Australia markets closed

Zealand Pharma A/S (22Z.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
122.80+0.40 (+0.33%)
As of 02:16PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
367,972
342,788
103,986
108,546
192,001
-
Cost of revenue
33,259
19,174
0
10,970
0
-
Gross profit
334,713
323,614
103,986
97,576
192,001
-
Operating expenses
Research development
789,526
684,902
614,044
581,511
595,847
-
Selling general and administrative
143,540
89,849
306,541
298,209
222,389
-
Total operating expenses
1,071,409
900,831
920,585
879,720
818,236
-
Operating income or loss
-736,696
-577,217
-816,599
-782,144
-626,235
-
Interest expense
-82,647
24,888
56,455
4,091
2,895
-
Total other income/expenses net
-
-
-
30,777
-4,068
9,242
Income before tax
-716,558
-708,865
-972,041
-758,887
-673,527
-
Income tax expense
-4,554
-5,126
-6,431
-3,949
-4,814
-
Income from continuing operations
-712,004
-703,739
-965,610
-754,938
-668,713
-
Net income
-712,004
-703,739
-1,202,135
-1,018,149
-846,729
-
Net income available to common shareholders
-712,004
-703,739
-1,202,135
-1,018,149
-846,729
-
Basic EPS
-14.58
-12.44
-26.02
-23.75
-22.07
-
Diluted EPS
-14.58
-12.44
-26.02
-23.75
-22.07
-
Basic average shares
54,753
56,589
46,200
42,869
38,370
-
Diluted average shares
54,753
56,589
46,200
42,869
38,370
-